Han Wu Selected Research

Syndecan-4

1/2022	A reduction of Syndecan-4 in macrophages promotes atherosclerosis by aggravating the proinflammatory capacity of macrophages.
5/2017	Syndecan-4 deficiency accelerates the transition from compensated hypertrophy to heart failure following pressure overload.
9/2016	Syndecan-4 Signaling Is Required for Exercise-Induced Cardiac Hypertrophy.
1/2016	Syndecan-4 shedding impairs macrovascular angiogenesis in diabetes mellitus.
1/2015	Syndecan-4 shedding is involved in the oxidative stress and inflammatory responses in left atrial tissue with valvular atrial fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Han Wu Research Topics

Disease

69	Neoplasms (Cancer) 09/2022 - 06/2012
22	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2012
20	Inflammation (Inflammations) 01/2022 - 10/2012
14	Infections 01/2022 - 01/2016
12	Fibrosis (Cirrhosis) 02/2022 - 10/2013
9	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022 - 01/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2011
6	Carcinogenesis 09/2020 - 07/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 12/2014
5	Atherosclerosis 01/2022 - 05/2017
5	Atrial Fibrillation 03/2019 - 01/2015
5	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 01/2012
4	Pathologic Constriction (Stenosis) 01/2022 - 01/2020
4	Myocardial Infarction 01/2022 - 01/2017
4	Hemorrhage 01/2022 - 01/2011
4	Hypertension (High Blood Pressure) 01/2022 - 01/2008
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2017
4	Colonic Neoplasms (Colon Cancer) 09/2020 - 01/2016
4	Wounds and Injuries (Trauma) 08/2020 - 01/2014
3	Endometriosis 06/2022 - 01/2020
3	Cognitive Dysfunction 06/2022 - 01/2020
3	Stomach Neoplasms (Stomach Cancer) 05/2022 - 01/2016
3	Reperfusion Injury 01/2022 - 12/2018
3	Infarction (Infarctions) 01/2022 - 01/2011
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
3	Glioma (Gliomas) 01/2022 - 01/2018
3	Pain (Aches) 12/2021 - 07/2018
3	Diabetes Mellitus 10/2021 - 01/2016
3	Obesity 05/2021 - 11/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2021
2	Azoospermia 11/2022 - 01/2017
2	Liver Neoplasms (Liver Cancer) 09/2022 - 02/2021
2	Parkinson Disease (Parkinson's Disease) 06/2022 - 01/2022
2	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2021
2	Ischemia 04/2022 - 01/2017
2	Postoperative Hemorrhage 03/2022 - 09/2021
2	Dermatitis 02/2022 - 01/2022
2	Pruritus (Itching) 02/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 01/2022 - 11/2018
2	COVID-19 01/2022 - 01/2022
2	Heart Failure 01/2022 - 05/2017

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2012
14	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2014
12	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2010
7	LipidsIBA 01/2022 - 02/2013
6	Pharmaceutical PreparationsIBA 09/2022 - 01/2019
6	Long Noncoding RNAIBA 01/2022 - 01/2017
6	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2012
6	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2015
6	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2016
6	CytokinesIBA 11/2020 - 10/2012
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 02/2022 - 01/2019
5	Syndecan-4IBA 01/2022 - 01/2015
4	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 12/2015
4	Fatty Acids (Saturated Fatty Acids)IBA 05/2021 - 02/2016
4	DNA (Deoxyribonucleic Acid)IBA 04/2021 - 01/2020
4	ChemokinesIBA 01/2021 - 01/2016
3	Circular RNAIBA 11/2022 - 01/2021
3	Therapeutic UsesIBA 01/2022 - 01/2017
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2019
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2015
3	Interleukin-12 (IL 12)IBA 01/2022 - 01/2016
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 07/2015
3	ORALIT (ORS)IBA 12/2021 - 05/2014
3	AntigensIBA 10/2021 - 01/2018
3	Biological ProductsIBA 01/2021 - 01/2020
3	Sincalide FDA Link 01/2021 - 01/2014
3	LigandsIBA 01/2021 - 10/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2021 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2016
3	Interleukin-6 (Interleukin 6)IBA 05/2017 - 01/2016
3	PeriostinIBA 07/2016 - 01/2015
3	EnzymesIBA 01/2016 - 06/2012
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2022 - 01/2021
2	C-PeptideIBA 01/2022 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 11/2021
2	Succinic Acid (Succinate)IBA 01/2022 - 01/2017
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2019
2	AntioxidantsIBA 01/2022 - 02/2018
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Apolipoproteins E (ApoE)IBA 01/2022 - 11/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2020
2	InterferonsIBA 01/2022 - 01/2013
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2020

Therapy/Procedure

20	Therapeutics 04/2022 - 01/2008
5	Hepatectomy 01/2022 - 01/2019
5	Sutures (Suture) 01/2022 - 05/2021
3	Length of Stay 03/2022 - 08/2020
3	Percutaneous Coronary Intervention 01/2020 - 10/2018
2	Drug Therapy (Chemotherapy) 05/2022 - 01/2022
2	Lymph Node Excision (Lymph Node Dissection) 04/2022 - 01/2018
2	Diskectomy (Discectomy) 03/2022 - 02/2013
2	Minimally Invasive Surgical Procedures 03/2022 - 01/2014
2	Blood Transfusion (Blood Transfusions) 02/2022 - 10/2021
2	Operative Surgical Procedures 01/2022 - 09/2021
2	Immunotherapy 01/2022 - 01/2021
2	Ligation 01/2022 - 01/2018